Overview
Aqdot develops and licenses AqFresh™ supramolecular chemistry technology using cucurbiturils for odour and VOC elimination, with applications in pharmaceutical encapsulation and controlled release. The platform supports targeted molecule capture and triggerable release, suitable for pharmaceutical industries alongside household, personal care, and agrichemicals. It offers drop-in solutions validated in industrial trials across over 10 industries, registered without hazard labelling in the EU.
Frequently asked questions
- What capabilities does Aqdot offer for pharmaceutical applications?
- Aqdot's AqFresh™ technology enables controlled encapsulation and triggered release of molecules using cucurbiturils, applicable to pharmaceuticals for advanced delivery systems.
- What regulatory approvals does Aqdot's core technology have?
- Aqdot's core technology, AqTMBit, is registered in the EU without hazard or classification labelling for health and environment. It holds four patents protecting the platform.
- In which geographies does Aqdot operate and license its technology?
- Headquartered in Cambridge, England, Aqdot licenses its technology globally, with EU regulatory registration and launches in over 10 industries worldwide.